MedPath

Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust

Not Applicable
Recruiting
Conditions
COVID-19
Trust
Registration Number
NCT06650462
Lead Sponsor
Old Dominion University
Brief Summary

The goal of this study is to assess how community-led group discussions about health-related topics may alter beliefs and intentions regarding healthcare recommendations, such as COVID-19 testing and vaccination.

Detailed Description

Eligible participants will be randomized to intervention or control group. Intervention group participants will meet virtually with other community member participants in small discussion groups once a week for one hour over the course of 12 weeks. The online discussion groups will be led by peer mentor facilitators and supported by a research team member. Discussion topics will include current events, COVID-19, and other health related topics. Control group participants will not meet in weekly discussion groups. At approximately the 0 month, 3 month, and 6 month time points, all participants will answer online surveys about health related topics. At the 3 month and 6 month time points, all participants will also be asked to self-administer a COVID-19 test that investigators provide. Finally, around the fourth month, intervention group participants will be invited to an online feedback session with the research team about participants' experiences in the study.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
72
Inclusion Criteria
  • 18 years or older
  • Resident of one of the 9 housing authority agencies
  • Willing to participate in Zoom meetings and complete online assessments at baseline, 3-month, and 6-month timepoints
  • Ability to read, speak, and understand English
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Openness to COVID-19 testing0 months, 3 months, 6 months

The COVID-19 Testing Openness Questionnaire is an 7-item self-report measure designed to assess participants' openness to getting tested for COVID-19. Each item is rated on a 5-point scale, from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging from 7 to 35. Higher scores indicate greater openness to COVID-19 testing.

COVID-19 Testing Efficacy0 months, 3 months, 6 months

The COVID-19 Testing Efficacy Scale is a 6-item self-report measure that will assess participants' perceived self- and response-efficacy related to COVID-19 testing. Each item is rated on a 5-point scale ranging from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging between 6 and 30. Higher scores indicate greater efficacy.

COVID-19 Trust0 months, 3 months, 6 months

The COVID-19 Trust Questionnaire is an 18-item self-report measure to assess participants' trust of information provided by various institutions and individuals relating to COVID-19. Each item is rated on a 5-point Likert scale, with the sum of scores ranging from 18 to 90. Higher scores indicate greater trust.

Qualitative feedback4 months

Qualitative feedback will be obtained from participants in a group feedback session

Secondary Outcome Measures
NameTimeMethod
COVID-19 Vaccine Hesitancy0 months, 3 months, 6 months

The Vaccine Hesitancy Questionnaire (VHQ) is an 18-item self-report measure that will assess participants' COVID-19 vaccine hesitancy. The VHQ was adapted from the Parent Attitudes about Childhood Vaccines (PACV) survey and contains 4 subscales: Immunization Behavior, Beliefs about Vaccine Safety and Efficacy, Attitudes about Vaccine Mandates and Exemptions, and Trust. Scores range from 11 to 85, with higher scores indicating greater hesitancy.

Trial Locations

Locations (1)

Macon & Joan Brock Virginia Health Institute at Old Dominion University

🇺🇸

Norfolk, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath